Bioanalytical Considerations for Clinical DDI Studies

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Resource

Bioanalytical Considerations for Clinical DDI Studies

Please complete the form below in order to access our resource:

A Message from Alturas President Robin Woods

Alturas Analytics Partners in Pioneering Space Research with Polaris Dawn Mission

Alturas Analytics, Inc. Appoints Erik Burns as Chief Marketing and Business Strategy Officer

A Busy Fall Ahead with Alturas!

Meet with Alturas in Boston! | PBSS Workshop on Small Molecules

Clinical Outsourcing Group – New England

PBSS-San Francisco Bay – Vendor Scientific Highlights Symposium: DMPK & Bioanalytical Technologies and Case Studies: Small Molecules, Peptides, Nucleotides, and Other Modalities

North Jersey Drug Metabolism Discussion Group (NJDMDG) Spring Symposium

AAPS eChalk Talk: Quantitation of a GLP-1 Agonist Panel to Support Microdosing Programs